Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Context Therapeutics Inc
(NQ:
CNTX
)
2.480
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.480
Bid (Size)
2.100 (5)
Ask (Size)
2.750 (1)
Prev. Close
2.480
Today's Range
2.480 - 2.480
52wk Range
0.7700 - 2.750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
August 07, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
August 01, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+100.00%
+100.00%
1 Month
-0.80%
-0.80%
3 Month
+21.57%
+21.57%
6 Month
+119.45%
+119.45%
1 Year
+127.69%
+127.69%
More News
Read More
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
July 10, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
Hypergrowth Hits: 3 Stocks Clocking Triple-Digit Gains with No End in Sight
May 30, 2024
Via
InvestorPlace
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
May 22, 2024
Via
InvestorPlace
CNTX Stock Earnings: Context Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
May 08, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 02, 2024
Via
Benzinga
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
May 02, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces $100 Million Private Placement
May 02, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
April 01, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
CNTX Stock Earnings: Context Therapeutics Misses EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
March 21, 2024
From
Context Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 15, 2023
Via
Benzinga
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
December 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 08, 2023
Via
Benzinga
Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
November 09, 2023
From
Context Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 31, 2023
Via
Benzinga
Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76
October 31, 2023
From
Context Therapeutics Inc.
Via
GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 02, 2023
Via
Benzinga
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
October 02, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.